Xlife Sciences AG (SWX:XLS)
Switzerland
· Delayed Price · Currency is CHF 22.10
-0.60 (-2.64%)
At close: Apr 3, 2025, 5:20 PM CET
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 130.91 million as of April 4, 2025. Its market cap has decreased by -54.46% in one year.
Market Cap
130.91M
Enterprise Value
280.42M
Revenue
990.27K
Ranking
n/a
PE Ratio
8.74
Stock Price
22.10
Market Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 130.91M, a decrease of -45.56%. That is a compound annual growth rate of -17.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2025 | 130.91M | -10.24% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 229.85B |
| Novartis AG | 183.72B |
| Alcon | 40.45B |
| Lonza Group AG | 39.12B |
| Galderma Group AG | 22.66B |
| Straumann Holding AG | 16.84B |
| Sandoz Group AG | 15.60B |
| Sonova Holding AG | 15.28B |